3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
102
Lung Neoplasms
39
Neoplasms
11
Neoplasm Metastasis
11
Colorectal Neoplasms
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Pancreatic Neoplasms
6
Mesothelioma, Malignant
5
Mesothelioma
5
Carcinoma
5
Ovarian Neoplasms
4
Meningeal Carcinomatosis
4
Melanoma
4
Colonic Neoplasms
4
Advanced Solid Tumors
4
Rectal Neoplasms
3
Adenocarcinoma of Lung
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Non-squamous Non-small Cell Lung Cancer
2
Neoplasms by Site
2
Lung Diseases
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Pancreatic Ductal
2
Carcinoma, Bronchogenic
2
Bronchial Neoplasms
2
Brain Neoplasms
2
Interventions
pembrolizumab
3
fludarabine
3
aldesleukin
3
Cyclophosphamide
3
cabozantinib
2
Specimen Handling
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Ipilimumab
2
CTLA-4 Antigen
2
olaparib
1
gallium 68 PSMA-11
1
enfortumab vedotin
1
darolutamide
1
Therapeutics
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Pluvicto
1
Mitomycin
1
Lutetium-177
1
Lutetium
1
Loperamide
1
Geriatric Assessment
1
Gemcitabine
1
Fulvestrant
1
Fluorouracil
1
Fecal Microbiota Transplantation
1
Exercise
1
Continuous Positive Airway Pressure
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urogenital Neoplasms
×
Pemetrexed
×
90 days
×
Clear all
No trials found.